BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27349189)

  • 1. Combination therapy in the management of giardiasis: What laboratory and clinical studies tell us, so far.
    Escobedo AA; Lalle M; Hrastnik NI; Rodríguez-Morales AJ; Castro-Sánchez E; Cimerman S; Almirall P; Jones J
    Acta Trop; 2016 Oct; 162():196-205. PubMed ID: 27349189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.
    Carter ER; Nabarro LE; Hedley L; Chiodini PL
    Clin Microbiol Infect; 2018 Jan; 24(1):37-42. PubMed ID: 28624613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway.
    Mørch K; Hanevik K; Robertson LJ; Strand EA; Langeland N
    J Infect; 2008 Apr; 56(4):268-73. PubMed ID: 18328567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study.
    Cañete R; Noda AL; Rodríguez M; Brito K; Herrera E; Kofoed PE; Ursing J
    Clin Microbiol Infect; 2020 Aug; 26(8):1092.e1-1092.e6. PubMed ID: 31901492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giardiasis treatment: an update with a focus on refractory disease.
    Mørch K; Hanevik K
    Curr Opin Infect Dis; 2020 Oct; 33(5):355-364. PubMed ID: 32773501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giardiasis: report of a case refractory to treatment.
    Iza JA; Iza SN; Olivera MJ
    Infez Med; 2019 Sep; 27(3):336-339. PubMed ID: 31545780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of chronic Giardia infection.
    Escobedo AA; Hanevik K; Almirall P; Cimerman S; Alfonso M
    Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1143-57. PubMed ID: 25059638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies for nitroimidazole-refractory giardiasis: a systematic review.
    Bourque DL; Neumayr A; Libman M; Chen LH
    J Travel Med; 2022 Jan; 29(1):. PubMed ID: 34350966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of silymarin in the treatment on asymptomatic Giardia infections in dogs.
    Chon SK; Kim NS
    Parasitol Res; 2005 Dec; 97(6):445-51. PubMed ID: 16151741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of refractory paediatric giardiasis using secnidazole plus albendazole: a case series.
    Escobedo AA; Almirall P; Chirino E; Pacheco F; Duque A; Avila I
    Infez Med; 2018 Dec; 26(4):379-384. PubMed ID: 30555145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome.
    Abboud P; Lemée V; Gargala G; Brasseur P; Ballet JJ; Borsa-Lebas F; Caron F; Favennec L
    Clin Infect Dis; 2001 Jun; 32(12):1792-4. PubMed ID: 11360222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of drugs for treating giardiasis: a systematic update of the literature and network meta-analysis of randomized clinical trials.
    Ordóñez-Mena JM; McCarthy ND; Fanshawe TR
    J Antimicrob Chemother; 2018 Mar; 73(3):596-606. PubMed ID: 29186570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of patients with refractory giardiasis.
    Nash TE; Ohl CA; Thomas E; Subramanian G; Keiser P; Moore TA
    Clin Infect Dis; 2001 Jul; 33(1):22-8. PubMed ID: 11389490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis.
    Solaymani-Mohammadi S; Genkinger JM; Loffredo CA; Singer SM
    PLoS Negl Trop Dis; 2010 May; 4(5):e682. PubMed ID: 20485492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study.
    Neumayr A; Schunk M; Theunissen C; Van Esbroeck M; Mechain M; Hatz C; Mørch K; Soriano Pérez MJ; Sydow V; Sothmann P; Kuenzli E; Rothe C; Bottieau E
    Clin Infect Dis; 2021 Oct; 73(8):1517-1523. PubMed ID: 34115100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 5-nitroimidazoles for the treatment of giardiasis: a systematic review of randomized controlled trials.
    Pasupuleti V; Escobedo AA; Deshpande A; Thota P; Roman Y; Hernandez AV
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2733. PubMed ID: 24625554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of antigiardial drugs.
    Wright JM; Dunn LA; Upcroft P; Upcroft JA
    Expert Opin Drug Saf; 2003 Nov; 2(6):529-41. PubMed ID: 14585063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative clinical trial of albendazole versus metronidazole in giardiasis.
    Misra PK; Kumar A; Agarwal V; Jagota SC
    Indian Pediatr; 1995 Mar; 32(3):291-4. PubMed ID: 8613282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled, open-label trial of a single day of mebendazole versus a single dose of tinidazole in the treatment of giardiasis in children.
    Cañete R; Escobedo AA; González ME; Almirall P; Cantelar N
    Curr Med Res Opin; 2006 Nov; 22(11):2131-6. PubMed ID: 17076973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013.
    Nabarro LE; Lever RA; Armstrong M; Chiodini PL
    Clin Microbiol Infect; 2015 Aug; 21(8):791-6. PubMed ID: 25975511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.